Faeth Therapeutics, Inc.
FTH· Nasdaq
Released Aug 3, 2023, before the open
10-Q filed Aug 3, 2023, 34 days after period end · 0000950170-23-038085
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$9.39M | -$10.54M | -$9.77M | -$4.91M |
| EPS Diluted | -$0.31 | -$0.34 | -$0.32 | -$3.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Faeth Therapeutics, Inc. · CIK 1829802 · Engraved from SEC EDGAR